| Key Financial Ratios of Jagsonpal Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
8.26 |
8.49 |
10.20 |
7.48 |
6.51 |
|
| Diluted EPS (Rs.) |
8.22 |
8.46 |
10.20 |
7.48 |
6.51 |
|
| Cash EPS (Rs.) |
9.56 |
9.13 |
10.66 |
8.06 |
6.71 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
36.14 |
70.88 |
60.65 |
46.96 |
43.55 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
36.14 |
70.88 |
60.65 |
49.95 |
46.54 |
|
| Dividend / Share(Rs.) |
2.50 |
5.00 |
5.00 |
4.00 |
1.00 |
|
| Revenue from Operations/Share (Rs.) |
40.47 |
78.94 |
90.36 |
86.30 |
71.74 |
|
| PBDIT/Share (Rs.) |
8.92 |
12.23 |
15.22 |
11.12 |
8.96 |
|
| PBIT/Share (Rs.) |
7.70 |
11.61 |
14.76 |
10.54 |
8.76 |
|
| PBT/Share (Rs.) |
10.52 |
11.30 |
13.29 |
10.43 |
8.35 |
|
| Net Profit/Share (Rs.) |
8.34 |
8.50 |
10.20 |
7.48 |
6.51 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
22.05 |
15.49 |
16.84 |
12.88 |
12.48 |
|
| PBIT Margin (%) |
19.02 |
14.70 |
16.34 |
12.20 |
12.21 |
|
| PBT Margin (%) |
25.99 |
14.31 |
14.70 |
12.08 |
11.63 |
|
| Net Profit Margin (%) |
20.60 |
10.76 |
11.28 |
8.66 |
9.07 |
|
| Return on Networth / Equity (%) |
23.07 |
11.98 |
16.81 |
15.92 |
14.95 |
|
| Return on Capital Employed (%) |
20.26 |
15.50 |
23.10 |
20.55 |
18.54 |
|
| Return on Assets (%) |
19.89 |
10.34 |
13.70 |
11.62 |
10.38 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.06 |
|
| Asset Turnover Ratio (%) |
1.08 |
1.01 |
1.30 |
1.36 |
114.45 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
6.22 |
10.42 |
5.97 |
3.24 |
2.98 |
|
| Quick Ratio (X) |
5.64 |
9.63 |
5.22 |
2.37 |
2.25 |
|
| Inventory Turnover Ratio (X) |
1.21 |
1.24 |
1.24 |
1.36 |
6.32 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
58.31 |
0.00 |
53.50 |
15.35 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
54.29 |
0.00 |
49.63 |
14.91 |
|
| Earnings Retention Ratio (%) |
0.00 |
41.69 |
0.00 |
46.50 |
84.65 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
45.71 |
0.00 |
50.37 |
85.09 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,305.18 |
591.93 |
644.85 |
795.42 |
154.96 |
|
| EV/Net Operating Revenue (X) |
4.86 |
2.84 |
2.72 |
3.52 |
0.82 |
|
| EV/EBITDA (X) |
22.02 |
18.30 |
16.17 |
27.31 |
6.60 |
|
| MarketCap/Net Operating Revenue (X) |
5.34 |
3.55 |
3.21 |
3.63 |
1.11 |
|
| Retention Ratios (%) |
0.00 |
41.68 |
0.00 |
46.49 |
84.64 |
|
| Price/BV (X) |
5.98 |
3.95 |
4.78 |
6.68 |
1.83 |
|
| Price/Net Operating Revenue |
5.34 |
3.55 |
3.21 |
3.63 |
1.11 |
|
| Earnings Yield |
0.04 |
0.03 |
0.04 |
0.02 |
0.08 |
|
Source : Dion Global Solutions Limited
